Envestnet Portfolio Solutions Inc. Sells 3,177 Shares of Encompass Health Corporation (NYSE:EHC)

Envestnet Portfolio Solutions Inc. lessened its holdings in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 33.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,311 shares of the company's stock after selling 3,177 shares during the quarter. Envestnet Portfolio Solutions Inc.'s holdings in Encompass Health were worth $639,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in EHC. Colonial Trust Co SC bought a new stake in shares of Encompass Health during the fourth quarter worth $29,000. Transce3nd LLC acquired a new position in Encompass Health in the 4th quarter worth $40,000. CBIZ Investment Advisory Services LLC increased its holdings in Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after purchasing an additional 127 shares in the last quarter. Signaturefd LLC raised its stake in shares of Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after purchasing an additional 125 shares during the period. Finally, Johnson Financial Group Inc. bought a new stake in shares of Encompass Health in the fourth quarter valued at about $72,000. 97.25% of the stock is currently owned by institutional investors.

Insider Activity at Encompass Health

In other news, EVP John Patrick Darby sold 10,000 shares of the stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total value of $1,147,900.00. Following the transaction, the executive vice president directly owned 79,710 shares of the company's stock, valued at $9,149,910.90. This represents a 11.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Mark J. Tarr sold 118,384 shares of Encompass Health stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the sale, the chief executive officer directly owned 527,070 shares of the company's stock, valued at $64,054,817.10. The trade was a 18.34% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 132,663 shares of company stock worth $16,034,082. Company insiders own 2.10% of the company's stock.

Encompass Health Stock Up 0.3%

EHC traded up $0.40 during trading on Monday, reaching $122.60. 453,129 shares of the stock were exchanged, compared to its average volume of 703,607. The stock has a market cap of $12.36 billion, a P/E ratio of 25.33, a price-to-earnings-growth ratio of 2.48 and a beta of 0.89. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.06 and a current ratio of 1.06. The stock's 50 day moving average price is $118.12 and its two-hundred day moving average price is $104.87. Encompass Health Corporation has a twelve month low of $82.74 and a twelve month high of $123.38.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. The company had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. During the same period in the prior year, the firm earned $1.12 EPS. Encompass Health's quarterly revenue was up 10.6% compared to the same quarter last year. Equities analysts expect that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.55%. The ex-dividend date is Tuesday, July 1st. Encompass Health's payout ratio is presently 14.05%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on EHC shares. Barclays increased their price objective on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a report on Friday, April 25th. UBS Group upped their price target on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Stephens raised shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target for the company in a research note on Thursday, June 5th. Wall Street Zen lowered shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Finally, KeyCorp increased their target price on shares of Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a report on Tuesday, May 27th. Eight equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $127.00.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.